197 related articles for article (PubMed ID: 30872624)
1. CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma.
McKenzie LD; LeClair JW; Miller KN; Strong AD; Chan HL; Oates EL; Ligon KL; Brennan CW; Chheda MG
Sci Rep; 2019 Mar; 9(1):4444. PubMed ID: 30872624
[TBL] [Abstract][Full Text] [Related]
2. ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state.
Chudnovsky Y; Kim D; Zheng S; Whyte WA; Bansal M; Bray MA; Gopal S; Theisen MA; Bilodeau S; Thiru P; Muffat J; Yilmaz OH; Mitalipova M; Woolard K; Lee J; Nishimura R; Sakata N; Fine HA; Carpenter AE; Silver SJ; Verhaak RG; Califano A; Young RA; Ligon KL; Mellinghoff IK; Root DE; Sabatini DM; Hahn WC; Chheda MG
Cell Rep; 2014 Jan; 6(2):313-24. PubMed ID: 24440720
[TBL] [Abstract][Full Text] [Related]
3. The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer.
Hou MF; Luo CW; Chang TM; Hung WC; Chen TY; Tsai YL; Chai CY; Pan MR
Exp Cell Res; 2017 Oct; 359(2):458-465. PubMed ID: 28842166
[TBL] [Abstract][Full Text] [Related]
4. CHD4 in the DNA-damage response and cell cycle progression: not so NuRDy now.
O'Shaughnessy A; Hendrich B
Biochem Soc Trans; 2013 Jun; 41(3):777-82. PubMed ID: 23697937
[TBL] [Abstract][Full Text] [Related]
5. CHD4 Has Oncogenic Functions in Initiating and Maintaining Epigenetic Suppression of Multiple Tumor Suppressor Genes.
Xia L; Huang W; Bellani M; Seidman MM; Wu K; Fan D; Nie Y; Cai Y; Zhang YW; Yu LR; Li H; Zahnow CA; Xie W; Chiu Yen RW; Rassool FV; Baylin SB
Cancer Cell; 2017 May; 31(5):653-668.e7. PubMed ID: 28486105
[TBL] [Abstract][Full Text] [Related]
6. NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.
Marques JG; Gryder BE; Pavlovic B; Chung Y; Ngo QA; Frommelt F; Gstaiger M; Song Y; Benischke K; Laubscher D; Wachtel M; Khan J; Schäfer BW
Elife; 2020 Aug; 9():. PubMed ID: 32744500
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways.
Zhou M; Sareddy GR; Li M; Liu J; Luo Y; Venkata PP; Viswanadhapalli S; Tekmal RR; Brenner A; Vadlamudi RK
Sci Rep; 2019 Apr; 9(1):6124. PubMed ID: 30992459
[TBL] [Abstract][Full Text] [Related]
8. SIRT6 coordinates with CHD4 to promote chromatin relaxation and DNA repair.
Hou T; Cao Z; Zhang J; Tang M; Tian Y; Li Y; Lu X; Chen Y; Wang H; Wei FZ; Wang L; Yang Y; Zhao Y; Wang Z; Wang H; Zhu WG
Nucleic Acids Res; 2020 Apr; 48(6):2982-3000. PubMed ID: 31970415
[TBL] [Abstract][Full Text] [Related]
9. CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.
Oyama Y; Shigeta S; Tokunaga H; Tsuji K; Ishibashi M; Shibuya Y; Shimada M; Yasuda J; Yaegashi N
PLoS One; 2021; 16(6):e0251079. PubMed ID: 34161330
[TBL] [Abstract][Full Text] [Related]
10. Acetyltransferase p300 collaborates with chromodomain helicase DNA-binding protein 4 (CHD4) to facilitate DNA double-strand break repair.
Qi W; Chen H; Xiao T; Wang R; Li T; Han L; Zeng X
Mutagenesis; 2016 Mar; 31(2):193-203. PubMed ID: 26546801
[TBL] [Abstract][Full Text] [Related]
11. Chromodomain helicase DNA-binding 4 (CHD4) regulates early B cell identity and V(D)J recombination.
Hagman JR; Arends T; Laborda C; Knapp JR; Harmacek L; O'Connor BP
Immunol Rev; 2022 Jan; 305(1):29-42. PubMed ID: 34927255
[TBL] [Abstract][Full Text] [Related]
12. Resistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4.
Guillemette S; Serra RW; Peng M; Hayes JA; Konstantinopoulos PA; Green MR; Cantor SB
Genes Dev; 2015 Mar; 29(5):489-94. PubMed ID: 25737278
[TBL] [Abstract][Full Text] [Related]
13. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
[TBL] [Abstract][Full Text] [Related]
14. The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.
Aguila B; Morris AB; Spina R; Bar E; Schraner J; Vinkler R; Sohn JW; Welford SM
Cancer Lett; 2019 Oct; 462():33-42. PubMed ID: 31377205
[TBL] [Abstract][Full Text] [Related]
15. ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
Dréan A; Rosenberg S; Lejeune FX; Goli L; Nadaradjane AA; Guehennec J; Schmitt C; Verreault M; Bielle F; Mokhtari K; Sanson M; Carpentier A; Delattre JY; Idbaih A
J Neurooncol; 2018 Jul; 138(3):479-486. PubMed ID: 29520610
[TBL] [Abstract][Full Text] [Related]
16. CHD4/NuRD complex regulates complement gene expression and correlates with CD8 T cell infiltration in human hepatocellular carcinoma.
Shao S; Cao H; Wang Z; Zhou D; Wu C; Wang S; Xia D; Zhang D
Clin Epigenetics; 2020 Feb; 12(1):31. PubMed ID: 32070428
[TBL] [Abstract][Full Text] [Related]
17. CHD4 as an important mediator in regulating the malignant behaviors of colorectal cancer.
Chang CL; Huang CR; Chang SJ; Wu CC; Chen HH; Luo CW; Yip HK
Int J Biol Sci; 2021; 17(7):1660-1670. PubMed ID: 33994851
[TBL] [Abstract][Full Text] [Related]
18. Rad51 protein expression and survival in patients with glioblastoma multiforme.
Welsh JW; Ellsworth RK; Kumar R; Fjerstad K; Martinez J; Nagel RB; Eschbacher J; Stea B
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1251-5. PubMed ID: 19545791
[TBL] [Abstract][Full Text] [Related]
19. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.
Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H
Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483
[TBL] [Abstract][Full Text] [Related]
20. DNA damage-induced NF-κB activation in human glioblastoma cells promotes miR-181b expression and cell proliferation.
Xu RX; Liu RY; Wu CM; Zhao YS; Li Y; Yao YQ; Xu YH
Cell Physiol Biochem; 2015; 35(3):913-25. PubMed ID: 25633526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]